The global market for human vaccines reached USD 43 billion in 2022 and is anticipated to reach USD 85.96 billion by 2032, with a projected annual revenue growth rate of 8% during the forecast period. This growth is attributed to the increasing prevalence of infectious diseases, a heightened focus on immunization programs, growing public awareness of the benefits of vaccination, and...